Bruker (BRKR) Invested Capital (2016 - 2025)
Bruker (BRKR) has disclosed Invested Capital for 16 consecutive years, with $2.5 billion as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Invested Capital rose 36.9% year-over-year to $2.5 billion, compared with a TTM value of $2.5 billion through Dec 2025, up 36.9%, and an annual FY2025 reading of $2.5 billion, up 36.9% over the prior year.
- Invested Capital was $2.5 billion for Q4 2025 at Bruker, down from $2.5 billion in the prior quarter.
- Across five years, Invested Capital topped out at $2.5 billion in Q3 2025 and bottomed at $965.0 million in Q3 2022.
- Average Invested Capital over 5 years is $1.6 billion, with a median of $1.5 billion recorded in 2023.
- The sharpest move saw Invested Capital tumbled 53.13% in 2022, then skyrocketed 39.7% in 2023.
- Year by year, Invested Capital stood at $2.4 billion in 2021, then crashed by 53.13% to $1.1 billion in 2022, then soared by 33.69% to $1.5 billion in 2023, then grew by 18.62% to $1.8 billion in 2024, then skyrocketed by 36.9% to $2.5 billion in 2025.
- Business Quant data shows Invested Capital for BRKR at $2.5 billion in Q4 2025, $2.5 billion in Q3 2025, and $1.9 billion in Q2 2025.